Skip to main content
Clinical Trials/NCT03247075
NCT03247075
Completed
N/A

Internet-delivered Cognitive Behavior Therapy Versus Internet-delivered Support and Counseling for Youth With Social Anxiety Disorder - A Randomized Controlled Trial

Karolinska Institutet1 site in 1 country103 target enrollmentSeptember 19, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Social Anxiety Disorder
Sponsor
Karolinska Institutet
Enrollment
103
Locations
1
Primary Endpoint
Clinician Severity Rating (CSR)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Social anxiety disorder among youth is highly prevalent and causes significant impairment in the lives of the affected. In spite of cognitive behavior therapy (CBT) being an effective treatment, research suggests that many young people with this disorder do not have access to good-quality CBT. Internet-delivered CBT could be an effective method to increase availability of evidence-based treatments for youth with social anxiety disorder. The primary objective of this study is to test the efficacy of internet-delivered CBT (ICBT) for youth (10 - 17 years) with social anxiety disorder. The investigators aim to conduct a randomized controlled trial with N = 101 participants. Participants will be randomized to either the active treatment arm (guided ICBT) or to a control condition (guided internet-delivered support and counseling). Follow-ups will be conducted at 3 and 12 months after post-assessment.

Registry
clinicaltrials.gov
Start Date
September 19, 2017
End Date
October 30, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eva Serlachius

Associate professor, child psychiatrist, MD

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • A principal diagnosis of social anxiety disorder, as defined by DSM-5
  • Age between 10 and 17 years
  • Ability to read and write Swedish
  • Daily access to the internet through a computer or similar device
  • A parent or caregiver that is able to co-participate in the treatment
  • Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment

Exclusion Criteria

  • Diagnosed with autism spectrum disorder, psychosis, bipolar disorder or severe eating disorder
  • Present risk of suicide
  • Ongoing alcohol or substance abuse
  • Occurrence of domestic violence
  • Completed CBT for any anxiety disorder within the last 6 months (defined as at least 5 sessions of CBT including in vivo exposure sessions)

Outcomes

Primary Outcomes

Clinician Severity Rating (CSR)

Time Frame: 6 months (14 months including follow-up)

A 0-8 rating by a professional assessor, specifying the severity of social anxiety

Secondary Outcomes

  • Anxiety Disorder Interview Schedule for DSM-IV, child and parent versions (ADIS C/P) - Comorbid disorders(Measured over the course of 6 months (14 months including follow-up))
  • Children's Global Assessment Scale (CGAS)(Measured over the course of 6 months (14 months including follow-up))
  • Client Satisfaction Questionnaire (CSQ-) - Child version(Measured only at post-treatment)
  • Anxiety Disorder Interview Schedule for DSM-IV, child and parent versions (ADIS C/P) - Social anxiety disorder(Measured over the course of 6 months (14 months including follow-up))
  • Clinical Global Impression - Improvement (CGI-I)(Measured over the course of 3 months (12 months including follow-up))
  • Liebowitz social anxiety scale for children and adolescents (LSAS-CA) - Child version(6 months (14 months including follow-up))
  • Liebowitz social anxiety scale for children and adolescents (LSAS-CA) - Parent version(Measured over the course of 6 months (14 months including follow-up))
  • Revised Children´s Anxiety and Depression Scale - (RCADS) - Parent version(Measured over the course of 6 months (14 months including follow-up))
  • Revised Children´s Anxiety and Depression Scale - (RCADS) Depression sub scale - Child version(Measured over the course of 6 months (14 months including follow-up))
  • Anticipatory social behaviors scale (ASBQ)(Measured over the course of 6 months (14 months including follow-up))
  • Treatment credibility and expectancy - Parent version(Measured at one time-point, at week three in the allocated intervention.)
  • Education, Work and Social Adjustment Scale (EWSAS) - Parent version(Measured over the course of 6 months (14 months including follow-up))
  • Client Satisfaction Questionnaire (CSQ-) - Parent version(Measured only at post-treatment)
  • Focus of attention questionnaire (FAQ)(Measured over the course of 6 months (14 months including follow-up))
  • The Subtle Avoidance Frequency Examination (SAFE)(Measured over the course of 6 months (14 months including follow-up))
  • Alcohol Disorder Identification Test (AUDIT)(Measured over the course of 6 months (14 months including follow-up))
  • Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) - Child version(Measured over the course of 6 months (14 months including follow-up))
  • The Negative Effects Questionnaire (NEQ)(Measured only at post-treatment)
  • Post-event processing questionnaire revised (PEPQ-R)(Measured over the course of 6 months (14 months including follow-up))
  • The Child Health Utility 9D (CHU 9D) - Child version(Measured over the course of 6 months (14 months including follow-up))
  • Internet intervention Patient Adherence Scale (iiPAS)(Measured at mid-treatment (week 5) and at post-treatment (week 10))
  • Treatment credibility and expectancy - Child version(Measured at one time-point, at week three in the allocated intervention.)
  • Hospital Anxiety and Depression Scale (HADS)(Measured only at pre-treatments)
  • Drug Use Disorders Identification Test (DUDIT)(Measured over the course of 6 months (14 months including follow-up))
  • Family Accommodation Scale-Anxiety (FASA)(Measured over the course of 6 months (14 months including follow-up))
  • School absenteeism(Measured over the course of 6 months (14 months including follow-up))

Study Sites (1)

Loading locations...

Similar Trials